Abstract:Self-assembling nanoparticles (saNP) and nanofibers were found in the recombinant coronavirus SARS-CoV-2 S1, S2, RBD and N proteins purified by affinity chromatography using Ni Sepharose. Scanning electron (SEM), atomic force (AFM) microscopy on mica or graphite surface and in liquid as well as dynamic light scattering (DLS) revealed nanostructures of various sizes. AFM in liquid cell without drying on the surface showed mean height of S1 saNP 80.03 nm, polydispersity index (PDI) 0.006; for S2 saNP mean height 93.32 nm, PDI = 0.008; for N saNP mean height 16.71 nm, PDI = 0.99; for RBD saNP mean height 16.25 nm, PDI = 0.55. Ratios between the height and radius of each saNP in the range 0.1-0.5 suggested solid protein NP but not vesicles with internal empty spaces. The solid but not empty structures of the protein saNP were also confirmed by STEM after treatment of saNP with the standard contrasting agent uranyl acetate. The saNP remained stable after multiple freeze-thaw cycles in water and hyperosmotic solutions for 2 years at -20 °C. Receptor-mediated penetration of the SARS-CoV-2 S1 and RBD saNP in the African green mokey kidney Vero cells with the specific receptors for β-coronavirus reproduction was more efficient compared to unspecific endocytosis into MDCK cells without the specific receptors. Amyloid-like structures were revealed in the SARS-CoV-2 S1, S2, RBD and N saNP by means of their interaction with Thioflavin T and Congo Red dyes. Taken together, spontaneous formation of the amyloid-like self-assembling nanostructures due to the internal affinity of the SARS-CoV-2 virion proteins might induce proteinopathy in patients, including conformational neurodegenerative diseases, change stability of vaccines and diagnostic systems.

Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils

Self-assembling amyloid-like nanostructures from SARS-CoV-2 S1, S2, RBD and N recombinant proteins

Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity

SARS-CoV-2 Nucleocapsid Protein Impairs SG Assembly by Partitioning into G3BP Condensate

Modular Characterization of SARS-CoV-2 Nucleocapsid Protein Domain Functions in Nucleocapsid-Like Assembly

Bioengineered self-assembled nanofibrils for high-affinity SARS-CoV-2 capture and neutralization

Understanding the Phase Separation Characteristics of Nucleocapsid Protein Provides a New Therapeutic Opportunity Against SARS-CoV-2

CryoEM and AI Reveal a Structure of SARS-CoV-2 Nsp2, a Multifunctional Protein Involved in Key Host Processes.

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation

Crystal Structures of the SARS‐CoV‐2 Nucleocapsid Protein C‐terminal Domain and Development of Nucleocapsid‐targeting Nanobodies

Dynamic ensembles of SARS-CoV-2 N-protein reveal head-to-head coiled-coil-driven oligomerization and phase separation

Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2

Nucleocapsid proteins from human coronaviruses possess phase separation capabilities and promote FUS pathological aggregation

Crystal Structure of SARS-CoV-2 Nucleocapsid Protein RNA Binding Domain Reveals Potential Unique Drug Targeting Sites

Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia

Antiviral Drug Design Based on Structural Insights into the N-terminal Domain and C-terminal Domain of the SARS-CoV-2 Nucleocapsid Protein

Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine

Cryo-EM Structures Delineate a Ph-Dependent Switch That Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains

Distinct Effects of SARS‐CoV‐2 Protein Segments on Structural Stability, Amyloidogenic Potential, and α‐Synuclein Aggregation